Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients

NCT00138879 · clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

St Mark's Hospital Foundation